Award-winning stock screening & ranking tools for individual investors
We go to great lengths to ensure our financial and technical data is the most current and accurate information possible.
Get complete clarity with flexible viewing options that let you to see the information that is important to you.
Stock screens save you time that can be better spent researching fewer stocks that meet your criteria.
Trusted by both Private Investors and Wealth Managers
I run a $100M+ portfolio and a significant part of my investment strategy is based on a proprietary momentum-based model I have developed. I use the Stockopedia momentum stock screens to data mine in conjunction with my own data analysis to select investments. My strategy has been very successful - beating the S&P 500 annually. I'm not aware of another commercially available product that provides the data I require to implement my strategy.
CEO, TTP Investments
Easily draw up a shortlist of stocks to look into in greater detail
Whether you are looking for value, momentum or income opportunities we give you more than 65 pre-programmed "GuruScreens" to kick-start your search. We've curated the stock screener criteria of the greatest investment experts of all time saving you time and hassle in your hunt for winning investments.
Quickly compare the performance of different screening strategies. With the historic performance of each Guru strategy clearly displayed, you can see what investment styles work and what does not under different market conditions.
Build rules to compare stocks against their market and industry averages. Rank sectors by any data point - from simple fields like the Yield and P/E to complex composite measures like the Piotroski F Score or Altman Z-Score to assess financial health.
|
|
Name | P/E | Mrkt Cap | F-Score |
|---|---|---|---|---|
|
|
Symphony International Holdings | 3.8 | £270m |
7
|
|
|
Glaxosmithkline | 11.7 | £74,873m |
7
|
|
|
Spire Healthcare | 6.7 | £465.3m |
6
|
|
|
Md Medical Investments | 11.5 | £345.9m |
5
|
|
|
Caretech Holdings | 9.9 | £386.5m |
5
|
|
|
Indivior | 7.1 | £1,324m |
5
|
|
|
Alliance Pharma | 13.1 | £342m |
5
|
|
|
Puretech Health | 12.3 | £454.8m |
3
|
Hear what our subscribers have to say about the Stock Screener
Create customised screens & views to hunt for hidden gems
Powered by our proprietary institutional grade financial database, you can sift, sort and screen the market using hundreds of metrics. The data set includes the powerful StockRanks™ which assess the Quality, Value and Momentum of any share instantly. Ratios can be used on their own or combined to give you granular control over the stocks that are uncovered.
Filter for specific industries to plug diversification gaps in your portfolio, or restrict your search to specific exchanges or indices to find tax efficient investments. Our simple to use advanced filters provide unparalleled ways of slicing and dicing stock markets.
We help you drill deeper into the financial health of your shortlist with customisable data views. Tables can be edited to view any ratio in our database so you can view every company alongside the metrics you care about. At a glance you can isolate the best shares in the list. If numbers and ratios just aren’t your thing, results can be visualised through charts to help you spot trends and quickly identify opportunities.
Your stock screener saves me hours and hours of time finding out about the fundamentals of US and UK stocks. The depth of information on tap is impressive and the functionality, flexibility and the ease of use of the screener to let me analyse this information in the way I want is a godsend.
Trader, Educator & CEO The Stop Hunter
The award-winning way to improve your investing results
-
Best Investment
Tools Provider2021 -
Best Research
Service2021 -
Favorite Share
Research Platform2021 -
Best Investment
Software2019 | 2018 | 2016 -
Journalist of the Year &
UK’s Favourite Investor2018
Broaden your investment universe and stay totally informed
Great investors use strict criteria, but strict criteria can exclude so many shares in an individual market that you may be left with no candidate stocks. Stockopedia provides a pan-global financial market database which opens up immense opportunity to even the strictest of investors. Any country or region can be added to expand your screening universe.
Stay on top of the changes in stock screens by tracking the promotions & demotions lists - updated daily before the open. Find opportunities before other investors.
Feel more confident in your decisions with reliable financial data
Stockopedia is one of the few companies in the world that the markets giant Refinitiv (a Thomson Reuters company) partners with to serve the individual investor.
A subscription to Stockopedia will be one of the best investments you'll ever make...
After your free trial, plans start at just £295 per year. With a one month money back guarantee, there's no risk.
